The Vanguard Group 13D and 13G filings for PMV Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-13 5:12 pm Sale | 2023-12-29 | 13G | PMV Pharmaceuticals, Inc. PMVP | The Vanguard Group | 2,405,307 4.700% | -348,299 (-12.65%) | Filing |
| 2023-02-09 11:30 am Purchase | 2022-12-30 | 13G | PMV Pharmaceuticals, Inc. PMVP | The Vanguard Group | 2,753,606 6.030% | 105,660 (+3.99%) | Filing |
| 2022-02-10 08:32 am Purchase | 2021-12-31 | 13G | PMV Pharmaceuticals, Inc. PMVP | The Vanguard Group | 2,647,946 5.840% | 2,647,946 (New Position) | Filing |